摘要:
The present invention relates to nitrooxyderivatives or salts thereof having the following general formula (I): R—NR1c—(K)k0—(B)b0—(C)c0—NO2 (I) wherein c0, b0 and k0 are 0 or 1; R is the radical of an analgesic drug for chronic pain, for instance neurophatic pain; R1c is H or alkyl with from 1 to 5 carbon atoms; B is such that its precursor is selected from amino acids, hydroxy acids, polyalcohol, compounds; C is a bivalent radical containing an aliphatic, heterocyclic or aromatic radical.
摘要:
Nitrooxy derivatives of steroidal compounds of general formula B—X1—NO2 (I) or esters or salts thereof, wherein: B is a steroidal radical, X1 is a bivalent linking group comprising an aromatic or heterocyclic ring.
摘要:
ACE inhibitor nitroderivatives of formula (I): A-(X1—ONO2)s (I) having wider pharmacological activity and enhanced tolerability. They can be employed for treating cardiovascular and renal diseases and inflammatory processes.
摘要:
Nitro-oxyderivative compounds or salts thereof having the following general formula (I): A-(B)b0-(C)c0—NO2 wherein: c0 is an integer and is 0 or 1, b0 is an integer and is 0 or 1, A=R-T1-, wherein R is the radical of an analgesic drug for the chronic pain, in particular for the neuropathic pain; B is such that its precursor is selected from aminoacids, hydroxyacids, polyalcohols, compounds containing at least one acid function; C is a bivalent radical containing an aliphatic, heterocyclic or aromatic radical.
摘要翻译:具有以下通式(I)的硝基氧化衍生化合物或其盐:A-(B)b0-(C)c0-NO2其中:c0为整数,为0或1,b0为整数,为0或1 A = R-T1-,其中R是用于慢性疼痛的镇痛药物的基团,特别是神经性疼痛; B的前体选自氨基酸,羟基酸,多元醇,含有至少一个酸官能团的化合物; C是含有脂族,杂环或芳族基团的二价基团。
摘要:
Disclosed are adenosine A.sub.2a receptor antagonists of the formula ##STR1## wherein A is pyrazole, imidazole or triazole ring; R is ##STR2## R.sub.1 and R.sub.2 are independently H, OH, halogen, alkoxy, alkyl, nitro, amino, CN, haloalkyl, haloalkoxy, carboxy or carboxamido; or the OH group together with one of R.sub.1 or R.sub.2, or R.sub.1 and R.sub.2 together, form a methylenedioxy group;and n is 0-4;said compounds are useful in the treatment of cardiovascular, central nervous system, and respiratory diseases.
摘要:
The present invention relates to nitrooxyderivatives or salts thereof having the following general formula (I): R—NR1c—(K)k0—(B)b0—(C)c0—NO2 (I) wherein c0, b0 and k0 are 0 or 1; R is the radical of an analgesic drug for chronic pain, for instance neurophatic pain; R1c is H or alkyl with from 1 to 5 carbon atoms; B is such that its precursor is selected from amino acids, hydroxy acids, polyalcohol, compounds; C is a bivalent radical containing an aliphatic, heterocyclic or aromatic radical.
摘要翻译:本发明涉及具有以下通式(I)的硝基氧基衍生物或其盐:R-NR1c-(K)k0-(B)b0-(C)c0-NO2(I)其中c0,b0和k0为0或 1; R是用于慢性疼痛的止痛药的基础,例如神经性疼痛; R 1c是H或具有1至5个碳原子的烷基; B的前体选自氨基酸,羟基酸,多元醇,化合物; C是含有脂族,杂环或芳族基团的二价基团。
摘要:
Nitro-oxyderivative compounds or salts thereof having the following general formula (I): A-(B)b0-(C)o0-N02 wherein: c0 is an integer and is 0 or 1, b0 is an integer and is 0 or 1, A=R-TI-, wherein R is the radical of an analgesic drug for the chronic pain, in particular for the neuropathic pain; B is such that its precursor is selected from aminoacids, hydroxyacids, polyalcohols, compounds containing at least one acid function; C is a bivalent radical containing an aliphatic, heterocyclic or aromatic radical.
摘要翻译:具有以下通式(I)的硝基 - 氧化衍生化合物或其盐:A-(B)b0-(C)o0-N02其中:c0为整数,为0或1,b0为整数,为0或1 A = R-TI-,其中R是用于慢性疼痛的镇痛药物的基团,特别是神经性疼痛; B的前体选自氨基酸,羟基酸,多元醇,含有至少一个酸官能团的化合物; C是含有脂族,杂环或芳族基团的二价基团。
摘要:
Nitro-oxyderivative compounds or salts thereof having the following general formula (I): A-(B)b0—(C)c0—NO2 wherein: c0 is an integer and is 0 or 1, b0 is an integer and is 0 or 1, A=R-T1-, wherein R is the radical of an analgesic drug for the chronic pain, in particular for the neuropathic pain; B is such that its precursor is selected from aminoacids, hydroxyacids, polyalcohols, compounds containing at least one acid function; C is a bivalent radical containing an aliphatic, heterocyclic or aromatic radical.
摘要:
ACE inhibitor nitroderivatives of formula (I): A—(X1—ONO2)s (I) having wider pharmacological activity and enhanced tolerability. They can be employed for treating cardiovascular and renal diseases and inflammatory processes.